October 29, 2025

Hearing Loss Increased 56% Over 25-Year Cohort Follow-up

Two audiometry timepoints show the greatest hearing decline in high frequencies over 25 years.

Conexiant

October 29, 2025

Could the Way You Walk Change Outcomes?

Researchers find that the duration of walking bouts—not just total daily steps—predicts long-term cardiovascular and mortality risk.

Conexiant

October 29, 2025

H-1B Visa Changes: Who Pays the Price?

New fee structure could hit hardest where physicians are needed most.

Conexiant

October 29, 2025

What's Causing Sudden Cardiac Death?

Autopsies reveal faulty heart valves in the majority of SCD cases

The Pathologist

October 27, 2025

How Hormones May Influence Tirzepatide Outcomes

Researchers show how reproductive stage and hormone therapy influence weight-loss outcomes in women treated with tirzepatide.

Conexiant

October 23, 2025

Waist Loss Only Part of Semaglutide’s Power

Semaglutide lowered cardiovascular events in patients with overweight or obesity without diabetes, independent of weight loss.

Conexiant

October 23, 2025

Same Disease, Different DNA

Study finds Chinese heart disease patients have four times more rare genetic variants than UK counterparts

The Pathologist

October 22, 2025

Do GLP-1RAs Differ in Cardiometabolic Protection?

Researchers found that liraglutide and semaglutide offer similar cardiovascular and kidney benefits in type 2 diabetes.

Conexiant

October 20, 2025

FDA Okays First Oral GLP-1 for CV Risk

Novo Nordisk’s once-daily GLP-1 tablet reduced major adverse cardiovascular events in high-risk adults, including those without prior heart attack or stroke.

Conexiant